QNCX
Quince Therapeutics, Inc.
30.00$
-0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -100.0% | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | -85.5% | +95.5% | -81.4% | +100.0% | +9.4% | +2.9% | – | – | +163,788.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +140.0% | +7.8% | +12.0% | +18.5% | +18.5% | +39.8% | -19.5% | +23.3% | +55.9% | -45.7% | -20.2% | – | |
| – | +5.3% | +1.3% | -5.6% | -22.7% | +18.0% | +11.8% | -30.2% | -1.8% | +10.8% | +17.4% | +289.6% | – | |
| – | +36.9% | +34.5% | +151.3% | -79.2% | +72.1% | +47.2% | -33.6% | +36.2% | +20.9% | -31.8% | +620.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -346.7% | – | |
| – | – | – | +16.1% | -63.9% | -46.2% | +571.4% | +42.6% | -168.7% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -310.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -346.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.